Análisis coste-efectividad del alendronato frente a placebo en la prevención de fractura de cadera
a Farmacéutica Atención Primaria. Servicio de Farmacia Atención Primaria del Área 3. INSALUD. Madrid.
b Farmacéutica Atención Primaria. Servicio de Farmacia Atención Primaria del Área 8. INSALUD. Madrid.
c Profesor del Departamento de Planificación y Economía de la Salud. Escuela Nacional de Sanidad. Madrid.
Leído
5664
Vecesse ha leído el artículo
107
Total PDF
5557
Total HTML
Información del artículo
ISSN: 02126567Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2099 10 | 1777 | 0 | 1777 |
| 2025 12 | 9 | 0 | 9 |
| 2025 11 | 37 | 0 | 37 |
| 2025 10 | 18 | 0 | 18 |
| 2025 9 | 24 | 0 | 24 |
| 2025 8 | 37 | 0 | 37 |
| 2025 7 | 31 | 0 | 31 |
| 2025 6 | 34 | 0 | 34 |
| 2025 5 | 32 | 0 | 32 |
| 2025 4 | 33 | 0 | 33 |
| 2025 3 | 49 | 0 | 49 |
| 2025 2 | 34 | 0 | 34 |
| 2025 1 | 24 | 0 | 24 |
| 2024 12 | 22 | 0 | 22 |
| 2024 11 | 22 | 0 | 22 |
| 2024 10 | 33 | 0 | 33 |
| 2024 9 | 46 | 0 | 46 |
| 2024 8 | 24 | 0 | 24 |
| 2024 7 | 32 | 0 | 32 |
| 2024 6 | 43 | 0 | 43 |
| 2024 5 | 47 | 0 | 47 |
| 2024 4 | 43 | 0 | 43 |
| 2024 3 | 53 | 0 | 53 |
| 2024 2 | 47 | 3 | 50 |
| 2024 1 | 62 | 5 | 67 |
| 2023 12 | 53 | 1 | 54 |
| 2023 11 | 65 | 2 | 67 |
| 2023 10 | 111 | 6 | 117 |
| 2023 9 | 33 | 0 | 33 |
| 2023 8 | 22 | 2 | 24 |
| 2023 7 | 21 | 1 | 22 |
| 2023 6 | 25 | 1 | 26 |
| 2023 5 | 46 | 1 | 47 |
| 2023 4 | 10 | 0 | 10 |
| 2023 3 | 25 | 0 | 25 |
| 2023 2 | 20 | 1 | 21 |
| 2022 1 | 42 | 0 | 42 |
| 2022 12 | 29 | 0 | 29 |
| 2022 11 | 53 | 0 | 53 |
| 2022 10 | 26 | 0 | 26 |
| 2022 9 | 31 | 0 | 31 |
| 2022 8 | 39 | 0 | 39 |
| 2022 7 | 23 | 0 | 23 |
| 2022 6 | 55 | 0 | 55 |
| 2022 5 | 32 | 0 | 32 |
| 2022 4 | 33 | 1 | 34 |
| 2022 3 | 35 | 0 | 35 |
| 2022 2 | 21 | 0 | 21 |
| 2021 1 | 37 | 0 | 37 |
| 2021 12 | 55 | 0 | 55 |
| 2021 11 | 39 | 0 | 39 |
| 2021 10 | 38 | 2 | 40 |
| 2021 9 | 28 | 1 | 29 |
| 2021 8 | 22 | 0 | 22 |
| 2021 7 | 17 | 1 | 18 |
| 2021 6 | 32 | 0 | 32 |
| 2021 5 | 17 | 3 | 20 |
| 2021 4 | 41 | 4 | 45 |
| 2021 3 | 41 | 0 | 41 |
| 2021 2 | 17 | 0 | 17 |
| 2020 1 | 22 | 0 | 22 |
| 2020 12 | 13 | 0 | 13 |
| 2020 11 | 11 | 0 | 11 |
| 2020 10 | 11 | 1 | 12 |
| 2020 9 | 8 | 0 | 8 |
| 2020 8 | 14 | 0 | 14 |
| 2020 7 | 22 | 0 | 22 |
| 2020 6 | 20 | 0 | 20 |
| 2020 5 | 23 | 0 | 23 |
| 2020 4 | 15 | 0 | 15 |
| 2020 3 | 21 | 0 | 21 |
| 2020 2 | 31 | 0 | 31 |
| 2020 1 | 33 | 0 | 33 |
| 2019 12 | 28 | 0 | 28 |
| 2019 11 | 21 | 0 | 21 |
| 2019 10 | 20 | 0 | 20 |
| 2019 9 | 12 | 0 | 12 |
| 2019 8 | 6 | 0 | 6 |
| 2019 7 | 10 | 0 | 10 |
| 2019 6 | 49 | 0 | 49 |
| 2019 5 | 109 | 1 | 110 |
| 2019 4 | 38 | 0 | 38 |
| 2019 3 | 8 | 0 | 8 |
| 2019 2 | 12 | 0 | 12 |
| 2019 1 | 9 | 3 | 12 |
| 2018 12 | 6 | 0 | 6 |
| 2018 11 | 9 | 0 | 9 |
| 2018 10 | 19 | 0 | 19 |
| 2018 9 | 25 | 0 | 25 |
| 2018 8 | 5 | 0 | 5 |
| 2018 7 | 11 | 0 | 11 |
| 2018 6 | 12 | 0 | 12 |
| 2018 5 | 7 | 0 | 7 |
| 2018 4 | 16 | 0 | 16 |
| 2018 3 | 1 | 0 | 1 |
| 2018 2 | 7 | 0 | 7 |
| 2018 1 | 9 | 0 | 9 |
| 2017 12 | 8 | 0 | 8 |
| 2017 11 | 9 | 0 | 9 |
| 2017 10 | 8 | 0 | 8 |
| 2017 9 | 10 | 0 | 10 |
| 2017 8 | 10 | 1 | 11 |
| 2017 7 | 8 | 14 | 22 |
| 2017 6 | 17 | 17 | 34 |
| 2017 5 | 12 | 9 | 21 |
| 2017 4 | 13 | 4 | 17 |
| 2017 3 | 20 | 0 | 20 |
| 2017 2 | 22 | 0 | 22 |
| 2016 1 | 11 | 0 | 11 |
| 2016 12 | 19 | 4 | 23 |
| 2016 11 | 25 | 0 | 25 |
| 2016 10 | 32 | 1 | 33 |
| 2016 9 | 25 | 4 | 29 |
| 2016 8 | 25 | 1 | 26 |
| 2016 7 | 36 | 5 | 41 |
| 2016 6 | 35 | 0 | 35 |
| 2016 5 | 27 | 4 | 31 |
| 2016 4 | 45 | 1 | 46 |
| 2016 3 | 39 | 0 | 39 |
| 2016 2 | 40 | 1 | 41 |
| 2015 1 | 17 | 0 | 17 |
| 2015 12 | 16 | 0 | 16 |
| 2015 11 | 29 | 0 | 29 |
| 2015 10 | 33 | 0 | 33 |
| 2015 9 | 37 | 0 | 37 |
| 2015 8 | 35 | 0 | 35 |
| 2015 7 | 26 | 0 | 26 |
| 2015 6 | 22 | 0 | 22 |
| 2015 5 | 29 | 0 | 29 |
| 2015 4 | 23 | 0 | 23 |
| 2015 3 | 22 | 0 | 22 |
| 2015 2 | 13 | 0 | 13 |
| 2015 1 | 23 | 0 | 23 |
| 2014 12 | 13 | 0 | 13 |
| 2014 11 | 13 | 0 | 13 |
| 2014 10 | 13 | 0 | 13 |
| 2014 9 | 19 | 0 | 19 |
| 2014 8 | 15 | 0 | 15 |
| 2014 7 | 19 | 0 | 19 |
| 2014 6 | 10 | 0 | 10 |
| 2014 5 | 8 | 0 | 8 |
| 2014 4 | 10 | 0 | 10 |
| 2014 3 | 12 | 0 | 12 |
| 2014 2 | 5 | 0 | 5 |
| 2014 1 | 9 | 0 | 9 |
| 2013 12 | 6 | 0 | 6 |
| 2013 11 | 11 | 0 | 11 |
| 2013 10 | 7 | 0 | 7 |
| 2013 9 | 8 | 0 | 8 |
| 2013 8 | 5 | 0 | 5 |
Mostrar todo
